Core Viewpoint - 圣贝拉有限公司 (02508.HK) was listed on the Hong Kong Stock Exchange, closing at HKD 8.80, a rise of 33.74% from its final offering price of HKD 6.580 [1][3]. Summary by Relevant Sections Share Issuance and Capital Structure - The total number of shares offered globally by 圣贝拉 was 109,733,000, with 7,710,000 shares allocated for the Hong Kong public offering and 62,023,000 shares for international offering [1][2]. - At the time of listing, the total number of issued shares was 609,733,000 [2]. Financial Details - The total proceeds from the offering amounted to HKD 722.04 million, with net proceeds of HKD 629.95 million after deducting estimated listing expenses of HKD 92.09 million [3][4]. - The company plans to allocate approximately 29% of the net proceeds to expand its postpartum care network, 37% for launching new services and products, 6% for training family care professionals, 18% for research and development activities, and 9% for working capital and other general corporate purposes [4]. Financial Performance - 圣贝拉's revenue for the years 2022, 2023, and 2024 is projected to be RMB 471.52 million, RMB 559.91 million, and RMB 798.67 million, respectively [6][7]. - The company reported losses of RMB 411.58 million in 2022, RMB 238.89 million in 2023, and an expected loss of RMB 543.28 million in 2024 [6][7]. - The net cash flow from operating activities for the same years was RMB 24.11 million, RMB 56.70 million, and RMB 49.08 million, respectively [8].

Core Viewpoint - The successful IPOs of companies like Saint Bella, Zhou Li Fu, and Ying Tong Holdings highlight the booming "self-care consumption" trend, indicating that consumers are willing to pay a premium for professional services that enhance their quality of life [3][12]. Group 1: Company Overview - Saint Bella, known as the "first stock of global family quality care," had an IPO pricing of HKD 6.58 per share, with a first-day increase of 42%, reaching HKD 9.4 per share [1][4]. - The company reported revenues of CNY 472 million, CNY 560 million, and CNY 799 million for 2022, 2023, and 2024 respectively, marking a revenue growth of 67.3% over two years [4]. - Adjusted net profit shifted from a loss of CNY 44.63 million in 2022 to a profit of CNY 20.77 million in 2023, with further growth to CNY 42.26 million in 2024 [4]. Group 2: Business Model and Strategy - Saint Bella has redefined the traditional "postpartum care" model by adopting a "high-end hotel leasing + professional care output" strategy, significantly reducing initial investment costs while enhancing customer experience [4][6]. - The company operates a three-tier brand matrix targeting different customer segments, with the ultra-high-end brand contributing an average revenue of CNY 239,000 per customer in 2024 [5]. - The expansion into family health ecosystems includes home care services and the acquisition of a women's health food brand, leading to a revenue increase from CNY 64.19 million in 2022 to CNY 120 million in 2024 [6]. Group 3: Market Potential and Growth Drivers - The postpartum care and recovery service market is projected to reach CNY 67.5 billion in 2024, with a compound annual growth rate (CAGR) of 20.4% expected until 2030 [7]. - The penetration rate of postpartum care centers in China is currently at 6.0%, significantly lower than the 60% in mature markets like South Korea and Taiwan, indicating substantial market expansion potential [7][8]. - Saint Bella's competitive advantage lies in its professionalized service model, with 693 certified nurses and partnerships with over 30 nursing schools, enhancing service quality and customer satisfaction [8][9]. Group 4: Future Directions - The company plans to invest in AI and new retail strategies to enhance service quality and expand its product lines, including a focus on women's health throughout their life cycle [10][11]. - Saint Bella is also pursuing global expansion, with plans to open centers in international cities with large Chinese populations, leveraging existing demand to establish a foothold in new markets [11]. - The IPO reflects the capital market's recognition of the long-term value in family health management, marking a shift in consumer focus from emotional satisfaction to higher quality of life concerns [12].

Core Viewpoint - Saint Bella, known as the "first global family quality care stock," successfully listed on the Hong Kong Stock Exchange, raising approximately HKD 651 million, with a significant initial stock price increase, reflecting both opportunities and challenges in the high-end maternity care industry [2][3]. Group 1: Business Model and Strategy - Saint Bella employs a light-asset expansion strategy, controlling initial investment per store between RMB 8 million to 12 million, which is only 40% of the industry average [3]. - The company has established a unique "art therapy" system to alleviate postpartum depression and has a 100% certification rate for its nursing staff, enhancing its service quality [4]. - The founding team combines financial rigor and brand operation expertise, supported by over RMB 1 billion in funding from notable investors since 2018 [3][4]. Group 2: Financial Performance and Industry Challenges - From 2021 to 2023, Saint Bella's revenue grew from RMB 259 million to RMB 560 million, with a net profit of RMB 20.77 million in 2023 after previous losses, indicating a reliance on cost control [5]. - The industry faces structural challenges, including a significant decline in birth rates and a saturated market with over 12,000 maternity centers, many lacking proper qualifications [6]. - Price wars have led to a drastic drop in average package prices in the mid-market segment, creating pressure on profitability [6]. Group 3: Regulatory Environment and Industry Standards - The lack of national regulations has resulted in significant risks, including unregulated prepayment systems and unclear medical qualifications for some institutions [7]. - Saint Bella is actively involved in setting industry standards, advocating for mandatory disclosure of staff qualifications and third-party management of prepayment accounts [12]. Group 4: Future Outlook and Market Trends - The high-end market is projected to grow at a compound annual growth rate of 12.6% from 2025 to 2028, driven by the consumption upgrade of high-net-worth individuals [15]. - Saint Bella's long-term value will depend on its ability to create ecosystem synergies and navigate policy developments effectively [16].

Core Viewpoint - Saint Bella Inc. successfully listed on the Hong Kong Stock Exchange, raising approximately HKD 722 million through its IPO, with a strong demand reflected in the subscription rates of 193 times for the public offering and 15.59 times for the international offering [3][4]. Group 1: IPO Details - The IPO involved a global offering of 109.733 million shares, representing 18% of the total shares post-issue, priced at HKD 6.58 per share [3]. - The net proceeds from the IPO are approximately HKD 630 million [3]. - Seven cornerstone investors participated in the IPO, collectively subscribing to about USD 41.46 million (approximately HKD 325 million) of the shares [4]. Group 2: Shareholder Structure - After the IPO, the major shareholder, Xiang Hua, holds approximately 34.85% of the shares through Primecare BVI and Xiang SPV [5][6]. - Other notable investors include Tencent, Gaorong Capital, and China Life, among others, with Tencent holding 9.52% of the shares [5][6]. Group 3: Business Overview - Founded in November 2017, Saint Bella is a leading postpartum care and recovery group in China, offering services across 27 cities in mainland China, Hong Kong, Singapore, and the Greater Los Angeles area [6]. - The company operates three main business lines: postpartum care centers, home care services, and related food products [6]. - According to Frost & Sullivan, Saint Bella is the largest postpartum care group in Asia and China by revenue as of 2024, and it is also the fastest-growing scaled postpartum care group in China from 2022 to 2024 [6]. Group 4: Market Performance - Following the IPO, Saint Bella's stock price rose to HKD 9.00, marking a 36.78% increase, with a total market capitalization of approximately HKD 5.359 billion [7]. - The stock experienced a trading volume of 61.0437 million shares on its first day [8].

圣贝拉港股盘中涨近50%，报9.8港元。根据6月25日发布的最终发售价及配发结果的公告显示，圣贝拉 此次发售股份数目共计109733000股，其中香港发售股份数目为47710000股，国际发售股份数目为 62023000股。IPO募集所得款项总额722.04百万港元，净额为629.95百万港元。 ...

智通财经6月26日电，香港恒生指数开盘跌0.53%，恒生科技指数跌0.52%，中国月子中心圣贝拉香港首 日挂牌开盘报8.45港元，招股价为6.58港元。 ...

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司 （「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表 示概不就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任 何責任。 本公告不會直接或間接在或向美國（包括其領土及屬地、美國任何州以及哥倫比亞特區）發佈、 刊發或派發。本公告並非亦無意構成或組成於美國或任何其他司法管轄區購買或認購證券的 任何要約或招攬的一部分。發售股份不曾亦不會根據1933年美國《證券法》（經不時修訂）（「美 國《證券法》」）或美國任何州或其他司法管轄區的證券法登記，且不得在美國境內提呈發售、 出售、抵押或轉讓，惟獲豁免遵守或毋須遵守美國《證券法》登記規定及任何適用的州證券法 的交易除外。發售股份將不會於美國進行公開發售。發售股份僅可(1)根據美國《證券法》的登 記豁免向合資格機構買家（定義見美國《證券法》第144A條）；及(2)根據美國《證券法》S規例以 及進行發售及出售的各司法管轄區適用法例在美國境外以離岸交易方式提呈發售及出售。 本公告僅供參考，並不構成收購、購買或認購證券的邀請或要約。本公告並非 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或 因倚賴該等內容而引致的任何損失承擔任何責任。 （股份代號：2508） 董事名單及其角色與職能 SAINT BELLA Inc. 聖貝拉有限公司 （ 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） 梁珺先生 董事會設有三個委員會。下表載列各董事會成員於該等委員會中所擔任的職位： | 董事╱委員會 | 審核委員會 | 薪酬委員會 | 提名委員會 | | --- | --- | --- | --- | | 向華先生 | | | 主席 | | 梁珺先生 | 成員 | 成員 | | | 伍淑清女士 | 成員 | 主席 | 成員 | | Rainer Josef Bürkle先生 | | | | | 沈觀賢先生 | 主席 | 成員 | 成員 | 聖貝拉有限公司董事會（「董事會」）成員載列如下： 執行董事 獨立非執行董事 向華先生 伍淑清女士 Rainer Josef Bürkle先生 非執行董事 沈觀賢先生 香港，2025年6月25日 ...

（股份代號：2508） 提名委員會的職權範圍 聖貝拉有限公司（「本公司」）提名委員會（「提名委員會」）應由本公司董事會（「董 事會」）設立。下文載列提名委員會的職權範圍（「職權範圍」）。倘職權範圍的英 文及繁體中文版本有任何歧義，則以英文版本為準。 1. 目的 1.1 提名委員會的目的是物色、考慮並向董事會推薦合適的董事候選人擔任 本公司董事，監督評估董事會績效的程序，制定並向董事會推薦提名指引 及建議及本公司董事會多元化政策（「董事會多元化政策」），其應符合任 何適用的法律、法規及上市準則。 SAINT BELLA Inc. 聖貝拉有限公司 （ 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） 2. 成員 – 1 – 2.1 提名委員會的成員由董事會委任。提名委員會應由獨立非執行董事佔多數， 其符合香港聯合交易所有限公司證券上市規則（「上市規則」）（經不時修訂） 所規定的不時獨立性規定。 2.2 提名委員會主席必須由董事會主席或提名委員會內的獨立非執行董事擔任， 並由董事會委任。 3. 提名委員會秘書 4. 會議 – 2 – 3.1 提名委員會秘書須由本公司聯席秘書兼任。 3.2 提名委員會可不時 ...

SAINT BELLA Inc. 聖貝拉有限公司 （ 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） （股份代號：2508） 薪酬委員會的職權範圍 聖貝拉有限公司（「本公司」）薪酬委員會（「薪酬委員會」）應由本公司董事會（「董 事會」）設立。下文載列薪酬委員會的職權範圍（「職權範圍」）。倘職權範圍的英 文及繁體中文版本有任何歧義，則以英文版本為準。 1. 目的 2. 成員 2.1 薪酬委員會成員須由董事會委任。薪酬委員會大多數成員為不時符合香 港聯合交易所有限公司證券上市規則（「上市規則」）（經不時修訂）所訂明 獨立性規定的獨立非執行董事。薪酬委員會的組成須符合上市規則不時 的規定。 – 1 – 1.1 薪酬委員會的目的為於釐定董事及高級管理層薪酬政策及架構時向董事 會提供建議，建立正式及透明的政策制訂程序，評估董事及高級管理層表 現，審批獎勵計劃及董事服務合約的條款，以及就全體董事及高級管理層 的薪酬待遇提供建議。 1.2 薪酬委員會乃獨立公正的委員會，負責進行檢討並提出建議。該委員會在 所建議的待遇及╱或福利中概無任何個人財務利益，並在制訂該等薪酬 待遇時將顧及並適當考慮相關個人的表現水平及在 ...